HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margaret M McGovern Selected Research

Niemann-Pick Diseases (Niemann Pick Disease)

1/2018Burden of Illness in Acid Sphingomyelinase Deficiency: A Retrospective Chart Review of 100 Patients.
1/2017Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD).
1/2016Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency).
8/2013Morbidity and mortality in type B Niemann-Pick disease.
1/2013Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B.
8/2012Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B).
10/2006Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease.
5/2006Imprinting at the SMPD1 locus: implications for acid sphingomyelinase-deficient Niemann-Pick disease.
12/2004The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study.
7/2004Lipid abnormalities in children with types A and B Niemann Pick disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margaret M McGovern Research Topics

Disease

11Niemann-Pick Diseases (Niemann Pick Disease)
01/2018 - 07/2002
8Type B Niemann-Pick Disease
01/2016 - 12/2002
3Splenomegaly
10/2021 - 08/2008
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2018 - 10/2009
1Neurologic Manifestations (Neurological Manifestations)
01/2017
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2017
1Cytopenia
01/2017
1Respiratory Insufficiency (Respiratory Failure)
01/2017
1Fever (Fevers)
01/2016
1Drug-Related Side Effects and Adverse Reactions
01/2016
1Acute-Phase Reaction
01/2016
1Vomiting
01/2016
1Pain (Aches)
01/2016
1Nausea
01/2016
1Liver Failure
08/2013
1Lung Diseases (Lung Disease)
08/2013
1Fibrosis (Cirrhosis)
08/2013
1Rare Diseases (Rare Disease)
08/2012
1Cystic Fibrosis (Mucoviscidosis)
03/2009
1Breast Neoplasms (Breast Cancer)
01/2009
1Hepatomegaly
08/2008
1Peripheral Nervous System Diseases (PNS Diseases)
10/2006
1Hypersplenism (Anemia, Splenic)
12/2004
1Liver Diseases (Liver Disease)
12/2004
1Heart Diseases (Heart Disease)
07/2004
1Hypertriglyceridemia
07/2004
1Cardiovascular Diseases (Cardiovascular Disease)
07/2004
1Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
06/2003

Drug/Important Bio-Agent (IBA)

12neodymium pyrocatechin disulfonate (NPD)IBA
01/2017 - 07/2002
7LipidsIBA
01/2017 - 07/2002
6Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
01/2018 - 07/2002
6AcidsIBA
01/2018 - 07/2002
5SphingomyelinsIBA
01/2018 - 07/2002
2EnzymesIBA
01/2018 - 07/2002
2Biomarkers (Surrogate Marker)IBA
01/2016 - 08/2012
1olipudase alfaIBA
01/2016
1C-Reactive ProteinIBA
01/2016
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2016
1Interleukin-8 (Interleukin 8)IBA
01/2016
1Oxygen (Dioxygen)IBA
08/2013
1Indicators and Reagents (Reagents)IBA
01/2013
1DNA (Deoxyribonucleic Acid)IBA
03/2009
1Retinaldehyde (Retinal)IBA
10/2006
1HydrolasesIBA
05/2006
1BilirubinIBA
12/2004
1Transaminases (Aminotransferases)IBA
12/2004
1LDL CholesterolIBA
07/2004
1HDL CholesterolIBA
07/2004
1Glucose (Dextrose)FDA LinkGeneric
07/2004
1arginine butyrateIBA
06/2003
1Insulin (Novolin)FDA Link
04/2003

Therapy/Procedure

2Enzyme Replacement Therapy
01/2016 - 08/2008
2Therapeutics
08/2013 - 10/2009
1Splenectomy
10/2021
1Transplantation
08/2013
1Complementary Therapies (Alternative Medicine)
10/2009
1Mastectomy (Mammectomy)
01/2009